Stoke Therapeutics
STOK
STOK
133 hedge funds and large institutions have $744M invested in Stoke Therapeutics in 2025 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 50 increasing their positions, 34 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
133
Holders Change
+6
Holders Change %
+4.72%
% of All Funds
1.78%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
23
Increased
50
Reduced
34
Closed
17
Calls
$35K
Puts
$672K
Net Calls
-$637K
Net Calls Change
+$276K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$55.3M |
| 2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$10M |
| 3 |
Corient Private Wealth
Miami,
Florida
|
+$7.49M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.98M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.05M |
Top Sellers
| 1 |
ST
Skorpios Trust
Limassol,
Cyprus
|
-$41.4M |
| 2 |
CC
Checkpoint Capital
San Francisco,
California
|
-$4.86M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$4.79M |
| 4 |
Goldman Sachs
New York
|
-$4.09M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$2.65M |
